Table 3.

Hematocrit, lactate, and bone turnover marker responses before (PRE), immediately after RE (IP), and 30 min after RE (30P) for conditions (n=10; Mean ± SE).

Variables	WBV+RE	RE	Significant Effects	p
Hematocrit (%)a
PRE	46.6 ± 1.4	48.2 ± 0.9	Time	0.004
IP	49.9 ± 1.3	51.1 ± 1.2	IP>PRE	0.025
30P	47.4 ± 1.2	46.9 ± 0.7	IP>30P	0.005
Lactate (mmol/L)
PRE	1.11 ± 0.16	1.53 ± 0.41	Time	<0.001
IP	9.40 ± 0.91	9.08 ± 0.58	IP>PRE
Bone ALP (U/L)
PRE	42.08 ± 5.33	42.41 ± 4.45	Time	0.003
Uncorr IP	45.47 ± 5.41	47.54 ± 6.00	IP >PRE	0.013
Uncorr 30P	41.79 ± 5.60	43.03 ± 5.81	IP>30P	0.043
PRE a	42.57 ± 5.93	43.16 ± 4.90	N.S.
Corr IP a	42.15 ± 7.34	42.92 ± 5.45
Corr 30P a	42.23 ± 7.14	45.81 ± 6.43
TRAP5b (U/L)
PRE	3.21 ± 0.39	2.59 ± 0.22	Condition, Time	0.047, 0.036
Uncorr IP	3.27 ± 0.39	2.74 ± 0.24	Condition × Time	0.031
Uncorr 30P	2.98 ± 0.34	2.66 ± 0.21	WBV+RE PRE, IP>30P	0.016,0.014
PRE a	3.24 ± 0.44	2.57 ± 0.24	Time	0.024
Corr IP a	2.92 ± 0.45	2.39 ± 0.23	N.S. post hoc
Corr 30P a	2.98 ± 0.45	2.71 ± 0.22
CTX-I (ng/mL)
PRE	0.868 ± 0.127	0.743 ± 0.089	N.S.
Uncorr IP	0.853 ± 0.110	0.731 ± 0.065
Uncorr 30P	0.785 ± 0.125	0.716 ± 0.076
PRE a	0.890 ± 0.140	0.756 ± 0.099	N.S.
Corr IP a	0.779 ± 0.109	0.663 ± 0.065
Corr 30P a	0.805 ± 0.151	0.781 ± 0.092
CTX-I/TRAP5b ratio
PRE	0.274 ± 0.022	0.287 ± 0.022	N.S.
Uncorr IP	0.263 ± 0.016	0.269 ± 0.013
Uncorr 30P	0.254 ± 0.021	0.274 ± 0.026
PRE a	0.279 ± 0.024	0.293 ± 0.023	N.S.
Corr IP a	0.272 ± 0.016	0.278 ± 0.011
Corr 30P a	0.261 ± 0.023	0.288 ± 0.025

RE, resistance exercise; WBV, whole-body vibration; Bone ALP, bone-specific alkaline phosphatase; CTX-I, C-terminal telopeptides of type I collagen; TRAP5b, tartrate-resistant acid phosphatase 5b; Uncorr - uncorrected concentrations; Corr - corrected for plasma volume changes;

^an=9, N.S. - not significant.